MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 164 filers reported holding MIRATI THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is 0.50 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $4,102,000 | +128.8% | 55,956 | +32.4% | 0.01% | +66.7% |
| Q4 2018 | $1,793,000 | -51.4% | 42,275 | -46.1% | 0.00% | +50.0% |
| Q3 2018 | $3,690,000 | +116.2% | 78,360 | +126.3% | 0.00% | 0.0% |
| Q2 2018 | $1,707,000 | +1322.5% | 34,633 | +49.9% | 0.00% | – |
| Q1 2017 | $120,000 | +34.8% | 23,097 | +22.9% | 0.00% | – |
| Q4 2016 | $89,000 | -6.3% | 18,786 | +30.1% | 0.00% | – |
| Q3 2016 | $95,000 | +5.6% | 14,438 | -12.3% | 0.00% | – |
| Q2 2016 | $90,000 | -74.4% | 16,467 | 0.0% | 0.00% | -100.0% |
| Q1 2016 | $352,000 | -32.3% | 16,467 | 0.0% | 0.00% | 0.0% |
| Q4 2015 | $520,000 | +4.4% | 16,467 | +13.8% | 0.00% | 0.0% |
| Q3 2015 | $498,000 | +9.5% | 14,465 | 0.0% | 0.00% | 0.0% |
| Q2 2015 | $455,000 | +35.8% | 14,465 | +26.5% | 0.00% | 0.0% |
| Q1 2015 | $335,000 | +76.3% | 11,439 | +11.5% | 0.00% | – |
| Q4 2014 | $190,000 | +5.6% | 10,258 | 0.0% | 0.00% | – |
| Q3 2014 | $180,000 | -12.2% | 10,258 | 0.0% | 0.00% | – |
| Q2 2014 | $205,000 | – | 10,258 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aviva Holdings Ltd. | 3,135,966 | $116,595,216 | 81.37% |
| ORACLE INVESTMENT MANAGEMENT INC | 201,400 | $7,488,052 | 7.25% |
| Paradigm Biocapital Advisors LP | 1,396,779 | $51,932,243 | 4.92% |
| Octagon Capital Advisors LP | 750,000 | $27,885,000 | 4.01% |
| Boxer Capital, LLC | 2,000,000 | $74,360 | 3.65% |
| Artal Group S.A. | 1,537,709 | $57,172 | 3.40% |
| Avoro Capital Advisors LLC | 5,555,555 | $206,555,535 | 3.06% |
| RTW INVESTMENTS, LP | 3,643,114 | $135,450,979 | 2.82% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 244,000 | $9,071,920 | 2.53% |
| Kynam Capital Management, LP | 499,853 | $18,584,535 | 2.40% |